Western blotting revealed that isovalerylcarnitine (C5) markedly reduced CDH5 (VE-cadherin) and MMP2 expression (Fig. 6D,E), key mediators of GC metastasis, consistent with proteomic data showing their upregulation in GC (Fig. 6F). The gene discussed is CDH5; the disease is gastric cancer.